Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sequence A | Experimental | Period 1 : Reference drug(AD-2301), Period 2 : Test drug(AD-230) Single oral dose administration of AD-2301 three times in Period 1, followed by single oral dose administration of AD-230 twice in Period 2. |
|
| Sequence B | Experimental | Period 1 : Test drug(AD-230), Period 2 : Reference drug(AD-2301) Single oral dose administration of AD-230 twice in Period 1, followed by single oral dose administration of AD-2301 three times in Period 2 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AD-230, AD-2301 | Drug | Oral administration of AD-230 or AD-2301, according to randomized sequence. |
|
| Measure | Description | Time Frame |
|---|---|---|
| AUClast | -24hours to 72hours | |
| Cmax | -24hours to 72hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sarah Yoon | Contact | 031-891-5576 | sryoon@addpharma.co.kr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kyungpook National university hospital | Seoul | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided